摘要
【目的】探讨肥胖对2型糖尿病(T2DM )患者尿白蛋白排泄的影响。【方法】选择本科收治的T2DM 患者105例,根据体质量指数(BMI ,kg/m^2)分为正常组(40例,18≤ BMI <24)、超重组(29例,24≤BMI <28)、肥胖组(36例,BMI ≥28)三组,比较三组患者24 h 尿微量白蛋白(mALB),随机尿微量白蛋白/肌酐(ACR)等相关指标水平;同时以腰臀比(WHR)分为肥胖组(51例,男 WHR >0.90,女 WHR >0.80 )、正常组(54例男 WHR ≤0.90,女 WHR ≤0.80 ),比较两组患者 mALB 、ACR 等相关指标水平。【结果】①根据BMI 分组,正常组 mALB 和 ACR 为[(100.98±70.42)mg/24 h 和(99.24±69.88)mg/g];超重组 mALB 和ACR 为[(214.37±102.69)mg/24 h 和(208.5±71.35)mg/g];肥胖组 mALB 和 ACR 为[(467.77±330.86) mg/24 h 和(424.49±131.38)mg/g];均较正常组明显升高,差异具有统计学意义( P < 0.05)。②根据 WHR分组,正常组 mALB 和 ACR 为[(132.06±98.98)mg/24 h 和(127.90±84.53)mg/g],肥胖组 mALB 和 ACR为[(406.37±312.09)mg/24 h 和(373.32±152.02)mg/g],较正常组明显升高,差异具有统计学意义( P <0.05)。【结论】mALB 、ACR 随 BMI 及 WHR 增高而增高,控制肥胖有利于预防糖尿病肾病(DN )的发生及延缓病程的进展。
[Objective] To explore the effects of obesity on excretion of urine protein in type 2 diabetics .[Methods] A total of 105 type 2 diabetics were enrolled and divided into normal weight ( n = 40 ,18 ≤ BMI 〈 24) ,over‐weight ( n = 29 ,24 ≤ BMI 〈 28) and obesity (n = 36 ,BMI ≥ 28) groups according to body mass index (BMI) .The levels of 24‐hour urine microalbumin (mAlb) and urinary albumin creatinine ratio (ACR) were compared for three groups .Also based upon waist‐hip ratio (WHR) ,they were divided into obesity ( n = 51 ,male WHR 〉 0 .90 ,female WHR 〉 0 .80) and normal control ( n = 54 ,male WHR ≤ 0 .90 ,female WHR ≤ 0 .80) groups for comparing the levels of mAlb and ACR .[Results] According to BMI ,24h Um‐Alb and ACR in overweight group (214 .37 ± 102 .69 ;208 .5 ± 71 .35)and obesity group (467 .77 ± 330 .86 ;424 .49 ± 131 .38) were markedly higher than that in normal weight group (100 .98 ± 70 .42 ;99 .24 ± 69 .88)( P 〈 0 .05) .According to WHR ,24h Um‐Alb and ACR significantly increased in obesity group versus normal control group (406 .37 ± 312 .09 ;373 .32 ± 152 .02 vs 132 .06 ± 98 .98 ;27 .90 ± 84 .53)( P 〈 0 .05) .[Conclusion]The levels of mAlb and ACR increase with greater BMI and WHR in type 2 diabetics .And obesity control may prevent the occurrence of diabetic nephropathy and delay progression .
出处
《医学临床研究》
CAS
2015年第6期1104-1106,共3页
Journal of Clinical Research